Vontier Corp. (VNT) Tops Q1 EPS by 8c, Revenues Beat; Offers 2Q & FY21 EPS Outlook

Go back to Vontier Corp. (VNT) Tops Q1 EPS by 8c, Revenues Beat; Offers 2Q & FY21 EPS Outlook
Savient Pharmaceuticals, Inc. (NYSE: VNT) Delayed: 36.56 --0 (-0%)
Previous Close $36.56    52 Week High $9.92 
Open $36.56    52 Week Low $9.10 
Day High $36.56    P/E N/A 
Day Low $36.56    EPS $-0.94 
Volume 280